Mentions
Extended reach
Total likes
Video views
AI synopsis
Many discussions encapsulated the significance of the CENSER trial by highlighting its findings, such as better shock control rates within the first six hours of treatment. Phrases like 'promising findings' and 'critical read' underscore the excitement and urgency among participants regarding early norepinephrine's potential. Additionally, comments on future research direction and applications in clinical settings show that contributors are thoughtfully engaging with the material.
The majority of discussions reflect a supportive view of the findings, indicating that many participants align with the conclusions of the CENSER trial regarding early norepinephrine use.
A high level of curiosity is evident, as numerous participants delve into specifics about the study and its relevance, suggesting significant interest in its implications for clinical practice.
While many posts reference the trial and its findings, the depth of engagement varies; some provide critical insights while others merely acknowledge the trial's existence.
The overall sentiment indicates a belief that the findings of this publication will greatly influence future practices in managing septic shock.
Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO el GASTO URINARIO. No tuvo efecto en mortalidad o necesidad de DIÁLISIS Am J Respir Crit Care Med. 2019 May 1;199(9):1097-05. doi: 10.1164/rccm.201806-1034OC. https://t.co/l06DVh3nTf
Permpikul et al found out that early (before receiving 30cc/KG of fluid resus) admin of NE was associated with increased shock control by 6hours of presentation. https://t.co/B8ISSjPLmh https://t.co/CFvvTVPJXt
Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/8c34XZxeux
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t.co/hA46XeUyzu
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/4a2YAePQhE
This video reviews critical findings on poor sleep as a risk factor for type 2 diabetes and emphasizes the role of early low-dose norepinephrine in septic shock management. Recent studies indicate that effective sleep…
Early antibiotics improve outcomes for septic patients. Recent trials support initiating low-dose norepinephrine to enhance shock control rates. This video discusses innovative strategies in fluid resuscitation and…
個人的には過去のCENSER trial(https://t.co/Ol5KqxR3s4)のような,Nad投与タイミングのtrialかと思っていたのですが,この昇圧薬の使い方だとガイドライン通り,という感じですね. 全体の重症度も低めですし,患者背景もわりと良さそうなので多少多めに輸液が入っても差が出なかったのかも,ですね.
@mina_el_naguib @norfolk_tim @jfdwolff @Coxe85 @Fawc2007 @RRT_NNUH These two trials looking at early shock control (NA within the hour) are encouraging: https://t.co/AVjUtvJuOL https://t.co/dtYN6CD33w And should really frame the approach to septic shock in the future (imo)
RT @CunninghamResus: @Paul_Wischmeyer @NEJM @WesElyMD @AvrahamCooperMD @TomVargheseJr @drdangayach @chungk1031 @eddyjoemd @iamyourgasman @K…
RT @CunninghamResus: @Paul_Wischmeyer @NEJM @WesElyMD @AvrahamCooperMD @TomVargheseJr @drdangayach @chungk1031 @eddyjoemd @iamyourgasman @K…
RT @CunninghamResus: @Paul_Wischmeyer @NEJM @WesElyMD @AvrahamCooperMD @TomVargheseJr @drdangayach @chungk1031 @eddyjoemd @iamyourgasman @K…
@Paul_Wischmeyer @NEJM @WesElyMD @AvrahamCooperMD @TomVargheseJr @drdangayach @chungk1031 @eddyjoemd @iamyourgasman @KhannaAshishCCM @toddrice_ICU @DogICUma As a student, my favorite ICU trials to learned about were CENSER (https://t.co/PH5WDqBdjF) and ANDROMEDA-SHOCK (https://t.co/Iv0Tjk8lde)
RT @MDVictorJimenez: @SCCMPresident @CritCareMed The results of the CENSER trial (a RCT) point in the opposite direction. https://t.co/nDYg…
@SCCMPresident @CritCareMed The results of the CENSER trial (a RCT) point in the opposite direction. https://t.co/nDYgdlknjq https://t.co/BZRFoBTq8m
Speaking of early NE in septic shock, someone please run a large scale follow up to the CENSER trial https://t.co/PH5WDqBdjF https://t.co/b14psvLuGQ
RT @SCCM_Anesth: There may be benefit to starting vasoactive meds early in the course of treatment for this patient population. The CENSER…
RT @SCCM_Anesth: There may be benefit to starting vasoactive meds early in the course of treatment for this patient population. The CENSER…
There may be benefit to starting vasoactive meds early in the course of treatment for this patient population. The CENSER trial, may glean more light on this subject. https://t.co/aB3wtdCJ7x
@awgaffney @elliotktannor @hswapnil @NephJC @NSMCInternship @hellokidneyMD @dr_missyhanna @SRameshMD @nephromythri We are still waiting on CLOVERS but I’m not sure the results will be compelling based on the patients I’ve seen enrolled CENSER is good for quicker BP control but not hard outcomes https://t.co/5EpBQLsiQL And of course the harms of positive fluid balance are known
@reverendofdoubt @TheSGEM @load_dependent Agree. But very appropriate to individualize MAP to baseline or organ perfusion. And when to start is an open question. My bias: earlier > later (based on CENSER https://t.co/sQW4zOguNm& low qual evidence) but we’re eagerly enrolling in CLOVERS.
RT @avkwong: CENSER trial - Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial #IFAD2020 https://t.co/o…
RT @avkwong: CENSER trial - Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial #IFAD2020 https://t.co/o…
RT @avkwong: CENSER trial - Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial #IFAD2020 https://t.co/o…
RT @avkwong: CENSER trial - Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial #IFAD2020 https://t.co/o…
CENSER trial - Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial #IFAD2020 https://t.co/onVZpUjGRl
RT @jwolpaw: @DanSaddawi @IARS_Journals Absolutely, all the time. The CENSER trial also suggested it is safe: CENSER: Early use of Norepine…
@DanSaddawi @IARS_Journals Absolutely, all the time. The CENSER trial also suggested it is safe: CENSER: Early use of Norepinephrine in Septic Shock Resuscitation Permpikul C, AJRCCM, 2019. Published online February 1. doi:10.1164/rccm.201806-1034OC
RT @jacksonmiamiEM: PGY1 John Marin brought some MICU updates to conference this morning: several trials have shown mortality benefit with…
PGY1 John Marin brought some MICU updates to conference this morning: several trials have shown mortality benefit with early pressor use in sepsis. Start norepi in the first hour if MAP <65 after 30cc/kg bolus. Check out CENSER and CLOVER trials for more https://t.co/9bk2FdrrFX
RT @CHESTCritCare: Permpikul et al found out that early (before receiving 30cc/KG of fluid resus) admin of NE was associated with increased…
Permpikul et al found out that early (before receiving 30cc/KG of fluid resus) admin of NE was associated with increased shock control by 6hours of presentation. https://t.co/B8ISSjPLmh https://t.co/CFvvTVPJXt
@virenkaul @iceman_ex This trial in blue journal suggests can be done safely in resource-less-intense environment https://t.co/8pC4aVnueo
@neurobloop @peterkinderman @SajjadFazel @jonathanstea Did you read the CENSER trial? Here were the harms they documented between early NE and standard care. https://t.co/wIQSKzAEmh https://t.co/lkKWPRis09
@neurobloop @peterkinderman @SajjadFazel @jonathanstea 5. Not sure what you mean 6. False, RCTs do look for harm but usually poorly. This RCT looked for harms. https://t.co/wIQSKzj2XH
@RuralEMPodcast @KirstyChallen @MaxHockstein @PulmCrit @reverendofdoubt @CAEP_Docs @ALiEMteam @stemlyns @EMSwami @srrezaie @AliRaja_MD @meganranney @EMNerd_ Here ya go https://t.co/wIQSKzAEmh
Early noradr in septic shock https://t.co/kmXO9pa41L
RT @umanamd: It’s Monday, and you know what that means… A new @TheSGEM episode! Blood Pressure – Do Better, Keep Rising with NorEpi https:…
It’s Monday, and you know what that means… A new @TheSGEM episode! Blood Pressure – Do Better, Keep Rising with NorEpi https://t.co/HW7P8PXW5B Permpikul et al. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER): A Randomized Trial. Respir Crit Care Med 2019. https://t.co/nFrBOFi6DA
Link to the original article https://t.co/wIQSKzAEmh
An interesting and relevant study to the effects of early norepinephrine on patients in Septic Shock. Certainly food for thought on how prehospital services manage these patient groups. https://t.co/u5g2APsrlV
RT @TheSGEM: Next up on the SGEM is this paper on norepinephrine for sepsis. Guesses on theme music? https://t.co/wIQSKzAEmh @KirstyChall…
RT @TheSGEM: Next up on the SGEM is this paper on norepinephrine for sepsis. Guesses on theme music? https://t.co/wIQSKzAEmh @KirstyChall…
Next up on the SGEM is this paper on norepinephrine for sepsis. Guesses on theme music? https://t.co/wIQSKzAEmh @KirstyChallen @browofjustice @ketaminh @broomedocs @ffolliet @DrSimonMc @ianlewins @KariSampsel
@JP_Domecq Careful...recall that a prospective (though single center trial) showed no mortality benefit; identified within 25 min of ED arrival with meeting criteria more than one hour before randomization were excluded #CensorTrial https://t.co/aR21Nkjt6u
@ellamimasamayor Eto nga po eh... CENSER Trial (2019) says early use of NE more beneficial.
RT @jes4bris: #icssoa. Editors Cut - Top paper at AJRCCM 2019. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). American…
RT @jes4bris: #icssoa. Editors Cut - Top paper at AJRCCM 2019. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). American…
#icssoa. Editors Cut - Top paper at AJRCCM 2019. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). American Journal of Respiratory and Critical Care Medicine https://t.co/IOL8486gTS
Next up at #ICSSOA is Hannah Wunsch from the @ATSBlueEditor presents CENSER Trial. https://t.co/bVdh3vSDWR https://t.co/rLg8rreYAx
RT @DanielJafari: #CENSER trial: early fixed dose norepi in septic shock improves perfusion markers, but not powered to assess mortality be…
#CENSER trial: early fixed dose norepi in septic shock improves perfusion markers, but not powered to assess mortality benefit (6% lower). Interesting, as norepi is not used at fixed rate for septic shock. No diff in complications. #FOAMed #foamcc https://t.co/J6KJufhSEs
RT @themattmak: Paper 8 - Early vasopressors in septic shock? This paper shows better control of shock and less pulmonary oedema (no statis…
RT @DrSimonAshworth: Early Norad in Septic Shock (CENSER) Promising findings with regard to shock control, and pulmonary oedema. Big mort…
Early Norad in Septic Shock (CENSER) Promising findings with regard to shock control, and pulmonary oedema. Big mortality advantage 21%v15%, but p=0.15… so “more grants needed” Probably represents the best available evidence though https://t.co/Kfla7MOUCs
RT @themattmak: Paper 8 - Early vasopressors in septic shock? This paper shows better control of shock and less pulmonary oedema (no statis…
RT @themattmak: Paper 8 - Early vasopressors in septic shock? This paper shows better control of shock and less pulmonary oedema (no statis…
Paper 8 - Early vasopressors in septic shock? This paper shows better control of shock and less pulmonary oedema (no statistical difference in mortality) #RCEMASC https://t.co/QhqeWKd6Ni
RT @ATSCritCare: For patients with sepsis, earlier control of shock, less CHF and fewer arrhythmias with earlier norepinephrine administrat…
@psirides @iceman_ex @GongGasGirl @matttnz @Andyrooz22 But it is possible to give low dose vasopressors on the ward. You just need to “blind” it so people don’t know what they are giving
RT @adamdavidthomas: @laxswamy Also... CENSER also adds to safety of PIV pressors. Not really contentious IMHO for 2019. https://t.co/V0Fnk…
@laxswamy Also... CENSER also adds to safety of PIV pressors. Not really contentious IMHO for 2019. https://t.co/V0Fnkuuimj
RT @accracpodcast: We invite you to share your thoughts on this article from May 2019 in AJRCCM: “Early Use of Norepinephrine in Septic Sho…
RT @accracpodcast: We invite you to share your thoughts on this article from May 2019 in AJRCCM: “Early Use of Norepinephrine in Septic Sho…
We invite you to share your thoughts on this article from May 2019 in AJRCCM: “Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER).” Have you begun to implement early norepinephrine in your practice? https://t.co/Dpa2OearIH #ACCRACpodcast #AJRCCM #anesthesiology
Early Norepinephrine in Septic Shock, interesting article in American Journal of Respiratory and Critical Care Medicine. https://t.co/Mo46oHzprC - https://t.co/lCfVJtMDcg
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
Étude sur l’utilisation précoce de la norépinéphrine chez les patients en choc septique https://t.co/UWIGi0y3eP https://t.co/HN6Fx1VdaD
@ogi_gajic @NickJohnsonMD @HeyDrNik @concernecus @Aidan_Baron @iceman_ex I will have to look closely at that paper. What do you make of CENSER? Granted, small single center and underpowered for mortality. https://t.co/1XNLSvSivq
@iwashyna @virenkaul @Terri_Hough @RAYGUNshirts @ogi_gajic @iceman_ex @gsmartinmd @DogICUma Perhaps from the beginning? https://t.co/pXicq4b0Fp
RT @NitinSeam: We discussed several interesting articles from 5/1 AJRCCM! @LachowiczMarrah on NETs, inflammasome in severe #asthma: https:…
We discussed several interesting articles from 5/1 AJRCCM! @LachowiczMarrah on NETs, inflammasome in severe #asthma: https://t.co/TvdUtWzcqx CENSER-early norepi in septic shock resus: https://t.co/uLBohTljVa
RT @emresidents: Critical Care Alert: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER): A Randomized Trial https://t.co/p…
RT @emresidents: Critical Care Alert: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER): A Randomized Trial https://t.co/p…
Critical Care Alert: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER): A Randomized Trial https://t.co/pAp7Qk1S0o #EMRACritCare @seanhickey92 @jpickosmed
EvidenceAlerts | Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial. https://t.co/bGSYnyl2kB #FOAMed
Next article! Early Use of NE in Septic Shock Resuscitation. https://t.co/2oOT33lgHN
Appealing concept to me. Makes a lot of sense. #Early Use of #Norepinephrine in Septic #Shock #Resuscitation (#CENSER). A Randomized Trial | American Journal of Respiratory and Critical Care Medicine #icu #fluid #ajrccm #sepsis #ATS2019 https://t.co/ITMYcNt4gp
RT @kazuki24_: 初期輸液（30ml/kg）投与前にNAd 0.05γを初期から投与したほうが、6時間以内にMAP 65mmHg、Lacの10%以上のクリアランスを達成する率が高い。Secondary outcomeだし有意差はないけども、28日死亡率も低下する。…
初期輸液（30ml/kg）投与前にNAd 0.05γを初期から投与したほうが、6時間以内にMAP 65mmHg、Lacの10%以上のクリアランスを達成する率が高い。Secondary outcomeだし有意差はないけども、28日死亡率も低下する。 https://t.co/kCXgUhLbfg https://t.co/aiNBSkONhT
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
RT @JonathanNefro: Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO…
Durante la REANIMACIÓN en SEPSIS e HIPOTENSIÓN, el uso temprano de NOREPINEFRINA aceleró el control del choque y AUMENTO el GASTO URINARIO. No tuvo efecto en mortalidad o necesidad de DIÁLISIS Am J Respir Crit Care Med. 2019 May 1;199(9):1097-05. doi: 10.1164/rccm.201806-1034OC. https://t.co/l06DVh3nTf
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
RT @ATSBlueEditor: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t…
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial https://t.co/ERvzx4UIVM https://t.co/hA46XeUyzu
Pendulum swings further from EGDT: phase 2 RCT shows increased control of septic shock at 6 hrs with early norepi https://t.co/R5qy1ixsq4
RT @SFMU_MS: Early norepinephrine was significantly associated with increased shock control by 6 hours.CENSER.A Randomized Trial. Am J Resp…
Early norepinephrine was significantly associated with increased shock control by 6 hours.CENSER.A Randomized Trial. Am J Respir Crit Care Med. 2019 https://t.co/UTLZEf1JNH sur le meme sujet :Sepsis 4.0. les 6 premières heures. Jean Louis VINCENT Bruxelles https://t.co/bNFAVrZLxo https://t.co/sVH4T0Tp9f
https://t.co/fLlLWW1RIW 敗血症に対する早期NAD投与と従来の投与方法で予後に差があるかを調べたRCT 結果は診断から6時間後のショックコントール成功率は早期群のほうが高かった(76.1%vs. 48.4%; P < 0.001)28日死亡率は差がなかった。心原性肺浮腫や新規不整脈は早期群の方が少なかった #当麻_循環
RT @ATSCritCare: For patients with sepsis, earlier control of shock, less CHF and fewer arrhythmias with earlier norepinephrine administrat…
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. - PubMed - NCBI https://t.co/5HZnnaG38l
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/155 (76.1%) vs. 75/155 (48.4%) - p<0.001. (Estudio clínico aleatorizado unicéntrico) Am J Respir Crit Care Med 2019. doi: 10.1164/rccm.201806-1034OC.
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
RT @AmbrizMau: Uso temprano de norepinefrina se asocia a mayor control del choque a las 6 horas en pacientes con sepsis e hipotensión: 118/…
@jasumback CENSER trial: earlier "shock control" time, but limited (or no) patient-oriented outcome benefit in septic shock https://t.co/NqGyfxWp1k #CCTMC19 @CCTMC1
RT @anesthesiaAMM: Critical Care @StanfordMed Journal Club this week Dr Hylton @DHyltonMD will be presenting: Early Use of Norepinephrine i…
Critical Care @StanfordMed Journal Club this week Dr Hylton @DHyltonMD will be presenting: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. - PubMed - NCBI https://t.co/ZEh7yomBCN
#Early Use of #Norepinephrine in #Septic #Shock #Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine Better control of #shock @ 6 hours. Concept makes sense to me. #sepsis #rct #icu #ajrccm https://t.co/ITMYcNt4gp
RT @CraigCCRNCEN: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. https://t.co/jPHDqpE4hh
RT @spwhitmore: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @spwhitmore: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @spwhitmore: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/BN2nIoO4uH
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. https://t.co/jPHDqpE4hh
RT @ventilacionmeca: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respirat…
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/npIhsAfhai
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @MarcLeone8: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. - PubMed - NCBI https://t.co/hCUsl…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
RT @TheARISEstudy: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respirator…
RT @ventilung1: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory a…
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/8c34XZxeux
RT @TheARISEstudy: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respirator…
RT @TheARISEstudy: Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respirator…
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/4a2YAePQhE
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. - PubMed - NCBI https://t.co/hCUslNBvDU
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/9BpgnjUfG0
RT @f_g_zampieri: Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/X6i2WjN2VI
RT @f_g_zampieri: Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
RT @f_g_zampieri: Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
RT @f_g_zampieri: Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
RT @f_g_zampieri: Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/3I1k6QwYe4
RT @f_g_zampieri: Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
RT @f_g_zampieri: Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq
Outstanding effort. Requires careful reading for all involved in early sepsis care https://t.co/G65oTmJWoq